Temporal dynamics of cerebrospinal fluid anti-aquaporin-4 antibodies in patients with neuromyelitis optica spectrum disorders
Authors:
- Simone MaderSMSimone Mader
- Kathrin SchandaKSKathrin Schanda
- Florian DeisenhammerFDFlorian Deisenhammer
- Nebojsa StojsavljevicNSNebojsa Stojsavljevic
- Jelena KosticJKJelena Kostic
- Thomas BergerTBThomas Berger
- Jelena DrulovicJDJelena Drulovic
- Markus ReindlMRMarkus Reindl
- 1 May 2011
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 234 (1-2) , 124-130
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technological Development of the Republic of Serbia (175031)
- Interdisciplinary Center for Research and Treatment (2007104)
This publication has 21 references indexed in Scilit:
- Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevanceJournal of Neuroinflammation, 2010
- Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivoAnnals of Neurology, 2009
- Neuromyelitis optica: Passive transfer to rats by human immunoglobulinBiochemical and Biophysical Research Communications, 2009
- Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis opticaAnnals of Neurology, 2009
- NMO-IgG DETECTED IN CSF IN SERONEGATIVE NEUROMYELITIS OPTICANeurology, 2009
- Aquaporin-4–binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2Journal of Experimental Medicine, 2008
- Antibody to aquaporin-4 in the long-term course of neuromyelitis opticaBrain, 2008
- Neuromyelitis optica pathogenesis and aquaporin 4Journal of Neuroinflammation, 2008
- Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis opticaNeurology, 2007
- NMO-IgG in the diagnosis of neuromyelitis opticaNeurology, 2007